Robert Perkins is a seasoned medical affairs executive with extensive leadership experience in the pharmaceutical industry. Currently serving as Vice President for Renal and Cardiovascular at Bayer, Perkins manages a large team and a significant budget to support innovative treatments for diabetic kidney disease and heart failure. Previously, at Novartis, Perkins led the strategic pre-launch efforts for Iptacopan, ensuring effective initiatives for rare glomerular disease diagnoses. During a tenure at AstraZeneca, Perkins directed medical support for a groundbreaking HIF-PH Inhibitor. With an AB in English Literature from Harvard University, an MD from the University of Pittsburgh School of Medicine, and an MPH in Epidemiology from Johns Hopkins University, Perkins combines a strong academic background with expertise in medical strategy and program development.
This person is not in any teams
This person is not in any offices